Laboratory dedicated mapping of genes for predictive oncological diagnostics of the “Digital genomics” Centre (Q11526): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): The TGM project aims at creating a new dedicated human genome mapping site for collaborative development and clinical research on new products for determining the early stages of cancer involving circulating blood cells. We are planning to make a major contribution to the development of the Thanotics in the Czech Republic, i.e. diagnostics based on diagnostics that lead to the personalisation of health care, efficiency gains and targeted therapi...) |
(Changed an Item) |
||
| Property / programme | |||
| Property / programme: Enterprise and Innovation for Competitiveness - CZ - ERDF / rank | |||
Normal rank | |||
Revision as of 17:51, 25 March 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Laboratory dedicated mapping of genes for predictive oncological diagnostics of the “Digital genomics” Centre |
Project in Czech Republic financed by DG Regio |
Statements
25,300,500.0 Czech koruna
0 references
50,601,000.0 Czech koruna
0 references
50 percent
0 references
31 March 2020
0 references
Institute of Applied Biotechnologies a.s.
0 references
50°5'1.93"N, 14°30'28.48"E
0 references
10800
0 references
10800
0 references
Záměrem projektu TGM je vytvoření nového pracoviště pro cílené mapování lidského genomu, které bude sloužit k kolaborativnímu vývoji a klinickému výzkumu nových produktů pro stanovení ranných stádií rakoviny s využitím cirkulujících buněk z krve. Plánujeme zásadním způsobem přispět k rozvoji Theranostiky v ČR, tedy terapie založené na diagnostice, která vede k personalizaci zdravotní péče, zvýšení efektivity a cílené terapie a výrazně snižuje léčebné náklady. a. (Czech)
0 references
The TGM project aims at creating a new dedicated human genome mapping site for collaborative development and clinical research on new products for determining the early stages of cancer involving circulating blood cells. We are planning to make a major contribution to the development of the Thanotics in the Czech Republic, i.e. diagnostics based on diagnostics that lead to the personalisation of health care, efficiency gains and targeted therapies, and significantly reduce the treatment costs. (English)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/17_093/0012409
0 references